Spectrum of MicroRNAs and Their Target Genes in Cancer: Intervention in Diagnosis and Therapy
Overview
Affiliations
Till date, several groups have studied the mechanism of microRNA (miRNA) biogenesis, processing, stability, silencing, and their dysregulation in cancer. The miRNA coding genes recurrently go through abnormal amplification, deletion, transcription, and epigenetic regulation in cancer. Some miRNAs function as tumor promoters while few others are tumor suppressors based on the transcriptional regulation of target genes. A review of miRNAs and their target genes in a wide range of cancers is attempted in this article, which may help in the development of new diagnostic tools and intervention therapies. The contribution of miRNAs for drug sensitivity or resistance in cancer therapy and opportunities of miRNAs in cancer prognosis or diagnosis and therapy is also presented in detail.
Shao X, Bai L, Liang J, Li M Discov Oncol. 2024; 15(1):403.
PMID: 39225917 PMC: 11372011. DOI: 10.1007/s12672-024-01282-9.
Kciuk M, Yahya E, Mohamed M, Abdulsamad M, Allaq A, Gielecinska A Cancers (Basel). 2023; 15(13).
PMID: 37444408 PMC: 10340789. DOI: 10.3390/cancers15133298.
Plant extracellular vesicles: A novel bioactive nanoparticle for tumor therapy.
Tan Z, Li J, Luo H, Liu Y, Jin Y Front Pharmacol. 2022; 13:1006299.
PMID: 36249740 PMC: 9559701. DOI: 10.3389/fphar.2022.1006299.
Non-coding RNAs: the silent regulators of health and diseases.
Chakravorty N Mol Biol Rep. 2022; 49(7):6971-6973.
PMID: 35467178 PMC: 9036841. DOI: 10.1007/s11033-022-07464-4.